Latest Soft tissue sarcoma Stories
CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, Nov. 14 /PRNewswire-FirstCall/ -- Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr.
SALT LAKE CITY, Nov.
Ziopharm Oncology, a biopharmaceutical company, has announced that the European Medicines Agency's Committee for Orphan Medicinal Products has issued a positive opinion regarding the company's application for orphan medicinal product designation for palifosfamide in the treatment of soft tissue sarcoma.
ZIOPHARM Oncology, Inc.
SALT LAKE CITY, Sept. 23, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corp.
REDWOOD CITY, Calif., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLDD), today announced that it has initiated a Phase 1/2 clinical trial of TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
SALT LAKE CITY, Sept.
An Italian-led international study has identified a tumor suppressor gene as the first independent prognostic biomarker in cases of soft tissue sarcoma. The scientists said they examined specimens taken from 41 patients with soft tissue cancer.
By Chotel, F Unnithan, A; Chandrasekar, C R; Parot, R; Jeys, L; Grimer, R J We have analysed the pattern of symptoms in patients presenting with synovial sarcoma to identify factors which led to long delays in diagnosis.
- One of a pair of round metal cymbals attached to the fingers and struck together for rhythm and percussion in belly dancing.